EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13)

Anders Östlund, Ahmed Waraky, Anna Staffas, Helene Sjögren, Barbara De Moerloose, Nira Arad-Cohen, Daniel Cheuk, Jose Maria Fernandez Navarro, Kirsi Jahnukainen, Gertjan J L Kaspers, Zhanna Kovalova, Ramune Pasauliene und 7 weitere

Genes, Chromosomes and Cancer · 2024

DOI: 10.1002/gcc.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Anders Östlund und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Translocation, Genetic, Chromosomes, Human, Pair 12, Proto-Oncogene Proteins c-ets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stiftelsen Assar Gabrielssons Fond, Cancerfonden, Barncancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is a recurrent translocation in AML in infants or very young children and was recently included in the World Health Organization (WHO) Classification of Hematolymphoid Tumors. AML with t(7;12) is reported to involve MNX1 and ETV6 signaling; however, the mechanism of leukemogenesis is not well understood, and the presence of MNX1 :: ETV6 fusion transcripts has only been confirmed in approximately 50% of cases. In contrast, high expression of MNX1 has been seen in all investigated cases. In this study, we investigated the clinical as well as biological characteristics of 12 pediatric AML with t(7;12) and performed whole transcriptome (WTS) and whole genome sequencing (WGS) on six of these. There was no significant difference in event‐free survival or overall survival of these t(7;12) AML patients compared with other AML in the same age group. Interestingly, WTS identified several fusion transcripts involving ETV6 but not together with MNX1 . WGS identified the genomic breakpoints and revealed that a common fusion partner on chromosome 7 was NOM1 . Principal component analysis (PCA) of the WTS data showed that all t(7;12) AML cases cluster together, separate from all other pediatric AML subtypes; all cases had high expression of MNX1 , MNX1‐AS1 , and MNX1‐AS2 . Hence, t(7;12) AML, despite expressing different fusion transcripts and with varying translocation breakpoints, constitutes a phenotypically homogenous subgroup. This underlines that the leukemia‐driving event most likely is ectopic expression of MNX1 and that this therefore should be the defining Classifying criteria of this type of AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTranslocation, GeneticChromosomes, Human, Pair 12Proto-Oncogene Proteins c-etsChromosomes, Human, Pair 7Transcription FactorsHumansMaleChildFemaleChild, PreschoolInfantETS Translocation Variant 6 ProteinOncogene Proteins, FusionRepressor ProteinsAdolescentHomeodomain Proteins

Stichwörter der Autor:innen

AMLMNX1chromosome translocationleukemia

Substanzen

Proto-Oncogene Proteins c-etsTranscription FactorsETS Translocation Variant 6 ProteinMNX1 protein, humanOncogene Proteins, FusionRepressor ProteinsHomeodomain Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
  • Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.
  • Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa, Israel.
  • Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital, University of Hong Kong, Hong Kong, China.

ORCID-Profile: Lars Palmqvist

Förderung

  • Stiftelsen Assar Gabrielssons Fond
  • Cancerfonden
  • Barncancerfonden
  • Västra Götalandsregionen

Zitieren

APA

Östlund, A., Waraky, A., Staffas, A., Sjögren, H., De Moerloose, B., Arad-Cohen, N., Cheuk, D., Navarro, J. M. F., Jahnukainen, K., Kaspers, G. J. L., Kovalova, Z., Pasauliene, R., Saks, K., Zeller, B., Norén-Nyström, U., Hasle, H., Fogelstrand, L., Abrahamsson, J., & Palmqvist, L. (2024). Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13). Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70003

Vancouver

Östlund A, Waraky A, Staffas A, Sjögren H, De Moerloose B, Arad-Cohen N, et al. Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13). Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.70003

BibTeX
@article{stlund2024,
  author = {Östlund, Anders and Waraky, Ahmed and Staffas, Anna and Sjögren, Helene and De Moerloose, Barbara and Arad-Cohen, Nira and Cheuk, Daniel and Navarro, Jose Maria Fernandez and Jahnukainen, Kirsi and Kaspers, Gertjan J L and Kovalova, Zhanna and Pasauliene, Ramune and Saks, Kadri and Zeller, Bernward and Norén-Nyström, Ulrika and Hasle, Henrik and Fogelstrand, Linda and Abrahamsson, Jonas and Palmqvist, Lars},
  title = {Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13)},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  doi = {10.1002/gcc.70003}
}
Kostenlos starten →